ng-nitroarginine methyl ester has been researched along with ALS - Amyotrophic Lateral Sclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fine, J; Francis, GJ; Frey, WH; Gordon, T; Hanson, LR; Liu, WQ; Martinez, JA; Pradzinsky, N; Toth, C; Wilson, M; Zochodne, D | 1 |
| Basso, M; Bendotti, C; Bonetto, V; Cantoni, L; Cheroni, C; D'Alessandro, G; De Biasi, S; Estevez, AG; Giordana, MT; Marino, M; Massignan, T; Nardo, G; Salmona, M; Samengo, G; Strong, MJ; Tartari, S | 1 |
| Weiss, JH; Yin, HZ | 1 |
| Cookson, MR; Eggett, CJ; Figlewicz, DA; Manning, P; McNeil, CJ; Menzies, FM; Shaw, PJ | 1 |
| Alladi, PA; Nalini, A; Raju, TR; Sathyaprabha, TN; Shobha, K; Vijayalakshmi, K | 1 |
| Ikeda, K; Iwasaki, Y; Kinoshita, M | 1 |
| Beal, MF; Cutting, FB; Dawson, TM; Dawson, VL; Facchinetti, F; Gurney, ME; Huang, PL; MacDonald, JE; Reif, D; Sasaki, M; Zhai, P | 1 |
| Doroudchi, MM; Durham, HD; Figlewicz, DA; Minotti, S | 1 |
8 other study(ies) available for ng-nitroarginine methyl ester and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
Topics: Action Potentials; Administration, Intranasal; Age Factors; Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Humans; Insulin; Mice; Mice, Transgenic; Motor Activity; Motor Neurons; Muscle Strength; Muscle, Skeletal; Mutation; Neural Conduction; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Peripheral Nerves; Signal Transduction; Spinal Cord; Superoxide Dismutase | 2008 |
Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.
Topics: Aconitate Hydratase; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Gel, Two-Dimensional; Humans; Immunohistochemistry; Mice; NG-Nitroarginine Methyl Ester; Protein Structure, Quaternary; Proteins; Proteomics; Reproducibility of Results; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spinal Cord; Stress, Physiological; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2009 |
Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biological Transport, Active; Cell Survival; Drug Synergism; Enzyme Inhibitors; Male; Motor Neurons; Nerve Degeneration; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Culture Techniques; Polymerase Chain Reaction; Rats; Rats, Transgenic; Receptors, AMPA; Spermine; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Vesicular Glutamate Transport Proteins | 2012 |
Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
Topics: Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Annexin A5; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Culture Media, Serum-Free; Enzyme Inhibitors; Free Radicals; Humans; Immunohistochemistry; Mutation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Time Factors; Transfection | 2002 |
Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Astrocytes; Biological Factors; Cell Death; Cells, Cultured; Cerebrospinal Fluid; Enzyme Inhibitors; Excitatory Amino Acid Transporter 2; Female; Glutamic Acid; Humans; Immunohistochemistry; Injections, Spinal; L-Lactate Dehydrogenase; Male; Middle Aged; Neurotoxins; NG-Nitroarginine Methyl Ester; Presynaptic Terminals; Rats; Spinal Cord; Up-Regulation | 2007 |
Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hand Strength; Indazoles; Mice; Mice, Neurologic Mutants; Motor Neuron Disease; Motor Neurons; Muscle Denervation; Muscle, Skeletal; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Vacuoles | 1998 |
Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Topics: Amidines; Amyotrophic Lateral Sclerosis; Animals; Catalysis; Enzyme Inhibitors; Indazoles; Isoenzymes; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phenotype; Spinal Cord | 1999 |
Nitrotyrosination contributes minimally to toxicity of mutant SOD1 associated with ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Death; Cell Survival; Cells, Cultured; Embryo, Mammalian; Enzyme Inhibitors; Glutamic Acid; Humans; Mice; Motor Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Superoxide Dismutase; Tyrosine | 2001 |